SLC2A4 and Hyperglycemia: The reduction in systemic endotoxemia may contribute to an increased expression of insulin‐stimulated glucose uptake protein markers, AktSer473 phosphorylation, and GLUT4 protein expression, in addition to the enhancement of the pAMPK activation, resulting in stimulated glucose uptake and reduced hyperglycemia subsequently (Figure 9).